Circulating plasma proteins and new-onset diabetes in a population-based study: proteomic and genomic insights from the STANISLAS cohort. Issue 3 (September 2020)

• Record Type: Journal Article
• Authors: Ferreira, João Pedro; Lamiral, Zohra; Xhaard, Constance; Duarte, Kévin; Bresso, Emmanuel; Devignes, Marie-Dominique; Le Floch, Edith; Roulland, Claire Dandine; Deleuze, Jean-François; Wagner, Sandra; Guerci, Bruno; Girerd, Nicolas; Zannad, Faiez; Boivin, Jean-Marc; Rossignol, Patrick
• Is Part Of: European journal of endocrinology. Volume 183:Issue 3(2020)
• Page Start: 285
• Page End: 295
• Publication Date: 2020-09
• Subjects: Endocrinology -- Periodicals; 616.4005
• DOI: 10.1530/EJE-20-0246
• Languages: English
• ISSNs: 0804-4643

Abstract

Abstract : Objective: : Determining the factors associated with new-onset pre-diabetes and type 2 diabetes mellitus (T2D) is important for improving the current prevention strategies and for a better understanding of the disease. Design: : To study the factors (clinical, circulating protein and genetic) associated with new onset pre-diabetes and T2D in an initially healthy (without diabetes) populational familial cohort with a long follow-up (STANISLAS cohort). Methods: : A total of 1506 participants attended both the visit 1 and visit 4, separated by ≈20 years. Over 400 proteins, GWAS and genetic associations were studied using models adjusted for potential confounders. Both prospective (V1 to V4) and cross-sectional (V4) analyses were performed. Results: : People who developed pre-diabetes ( n = 555) and/or T2D ( n = 73) were older, had higher BMI, blood pressure, glucose, LDL cholesterol, and lower eGFR. After multivariable selection, PAPP-A (pappalysin-1) was the only circulating protein associated with the onset of both pre-diabetes and T2D with associations persisting at visit 4 (i.e. ≈20 years later). FGF-21 (fibroblast growth factor 21) was a strong prognosticator for incident T2D in the longitudinal analysis, but not in the cross-sectional analysis. The heritability of the circulating PAPP-A was estimated at 44%. In GWAS analysis, the SNP rs634737 was associated with PAPP-A both at V1 and V4. External replication also showed lower levels of PAPP-A in patients with T2D. Conclusions: : The risk of developing pre-diabetes and T2D increases with age and with features of the metabolic syndrome. Circulating PAPP-A, which has an important genetic component, was associated with both the development and presence of pre-diabetes and T2D.